Author: NEUROPHET

Posted Date:

March 26, 2026

Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer’s Disease Therapies

NEUROPHET

March 26, 2026
Neurophet Secures FDA 510(k) Clearance for “Neurophet AQUA AD Plus,” Marking Its Third U.S. Regulatory Milestone

NEUROPHET

February 8, 2026